Cognitive behaviour therapy for schizophrenia: Relationship between anxiety symptoms and therapy

Psychology and Psychotherapy: Theory, Research and Practice

Volumn 79, Issue 2, 2006, Pages 153-164

  Naeem, Farooq ^a,c   Kingdon, David ^a   Turkington, Douglas ^b  

^a ROYAL SOUTH HANTS HOSPITAL   (United Kingdom)

^b Infirmary   (United Kingdom)

^c MOORGREEN HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; CHLORPROMAZINE; NEUROLEPTIC AGENT;

ADOLESCENT; ADULT; AGED; AKATHISIA; ANXIETY; ARTICLE; BEHAVIOR THERAPY; CLINICAL TRIAL; COGNITIVE THERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DEPRESSION; FEMALE; FOLLOW UP; HALLUCINATION; HUMAN; HUMAN RELATION; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MULTICENTER STUDY; NEGATIVE SYNDROME; PERSECUTORY DELUSION; PHYSICAL DISABILITY; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SCHIZOPHRENIA; SOCIAL INTERACTION; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; ANTIPSYCHOTIC AGENTS; ANXIETY; COGNITIVE THERAPY; DATA INTERPRETATION, STATISTICAL; FEMALE; HUMANS; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; SAMPLE SIZE; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; TREATMENT OUTCOME;

EID: 33745752884     PISSN: 14760835     EISSN: None     Source Type: Journal    
DOI: 10.1348/147608305X91538     Document Type: Article

References (23)

1. Abu-hljleh, N., Takriti, A., Sarhan, W., & Saad, A. (2000). Long term treatment of schizophrenia with Risperidone: An international, multi centre, open label trial. Arab Journal of Psychiatry, 11(2), 122-130.
2. Åsberg, M., Montgomery, S. A., Perris, C., Schalling, D., & Sedvall, G. (1978). A comprehensive psychopathological rating scale. Acta Psychiatrica Scandinavica, (Suppl. 271), 5-29.
3. Brown, D., & Pedder, J. (1991). Introduction to psychotherapy (2nd ed.). London: Routledge.
4. Cormac, I., Jones, C., & Campbell, C. (2002). Cognitive behaviour therapy for schizophrenia. Cochrane database of systemic reviews, (1):CD000524. Review.
5. Cosoff, S. J., & Hafner, R. J. (1999). The prevalence of co-morbid anxiety in schizophrenia, schizoaffective disorders and bipolar disorders. Australia and New Zealand Journal of Psychiatry, 32(1), 67-72.
6. David, A. S., Buchanan, A., Reed, A., & Almeida, O. (1992). The assessment of insight in psychosis. British Journal of Psychiatry, 161, 599-602.
7. Drury, V., Birchwood, M., Cochrane, R., & Macmillan, F. (1996). Cognitive therapy and recovery from acute psychosis: A controlled trial I. Impact on psychotic symptoms. British Journal of Psychiatry, 169(5), 593-601.
8. Emsley, R. A., Oosthuizen, P. P., Joubert, A. F., Roberts, M. C., & Stein, D. J. (1999). Depressive and anxiety symptoms in patients with schizophrenia and schizpohphreniform disorders. Journal of Clinical Psychiatry, 60(11), 747-751.
9. Glick, I. D., Lemmens, P., & Vester-Bokland, E. (2001). Treatment of the symptoms of schizophrenia: A combined analysis of double blind studies comparing risperidone with haloperidol and other antipsychotic agents. International Clinical Psychopharmacology, 16(5), 265-274.
10. Huppert, J. D., Weiss, K. A., Lim, R., Pratt, S., & Smith, T. E. (2001). Quality of life in schizophrenia. Schizophrenia Research, 51(2-3), 171-180.
11. Kuipers, E., Fowler, D., Garety, P., Chisholm, D., Freeman, D., Dunn, G., Bebbington, P., & Hadley, C. (1998). London East Anglia randomised controlled trial of cognitive behaviour therapy for psychosis. III. Follow up and economic evaluation at 18 months. British Journal of Psychiatry, 173, 61-68.
12. Kuipers, E., Garety, P., Fowler, D., Dunn, G., Bebbington, P., Freeman, D., & Hadley, C. (1997). London-East Anglia randomised controlled trial of cognitive-behavioural therapy for psychosis. I. Effects of the treatment phase. British Journal of Psychiatry, 171, 319-327.
13. Lewis, S. W., Tarrier, N., Haddock, G., Bentall, R., Kinderman, P., Kingdon, D., Drake, R., & Dunn, G. (2002). Randomised controlled trial of cognitive-behavioural therapy in early schizophrenia: Acute-phase outcomes. British Journal of Psychiatry, 181(43), S91-S97.
14. Lindenmayer, J. P., Volavka, J., Liberman, J., Sheitman, B., Citrome, L., Chakos, M., Czobor, P., Parker, B., & Iskander, A. (2001). Olanzapine for schizophrenia refractory to typical and atypical antipsychotic: An open label prospective trial. Journal of Clinical Psychopharmacology, 21(4), 448-453.
15. Moorey, H., & Soni, S. D. (1996). Anxiety symptoms in stable schizophrenics. Journal of Mental Health, 3(2), 257-262.
16. NICE (National Institute for Clinical Excellence) (2002). London.
17. Sensky, T., Turkington, D., Kingdon, D., Scott, J. L., Scott, J., Siddle, R., O'Carroll, M., & Barnes, T. R. (2000). Randomised controlled trial of cognitive behaviour therapy for persistent symptoms in schizophrenia resistant to medication. Archives of General psychiatry, 57, 165-172.
18. Tarrier, N., Wittkowski, A., Kinney, C., McCarthy, E., Morris, J., & Humphreys, L. (1999). Durability of the effects of cognitive behavioural therapy in the treatment of chronic schizophrenia: 12 months follow up. British Journal of Psychiatry, 174, 500-504.
19. Tarrier, N., Yusupoff, L., Kinney, C., McCarthy, E., Gledhill, A., Haddock, G., & Morris, J. (1998). Randomised controlled trial of intensive cognitive behaviour therapy for patients with chronic schizophrenia. British Medical Journal, 317, 303-307.
20. Turkington, D., Kingdon, D., & Turner, T. (2002). Effectiveness of a brief cognitive-behavioral therapy intervention in the treatment of schizophrenia. British Journal of Psychiatry, 180, 523-527.
21. Turnbull, G., & Bebbington, P. (2001). Anxiety and schizophrenic process: Clinical epidemiological evidence. Social Psychiatry and Psychiatric Epidemiology, 36(5), 235-243.
22. Tyrer, P., Owen, R. T., & Cicchetti, D. V. (1984). The brief scale for anxiety: A subdivision of the comprehensive psychopathological rating scale. Journal of Neurology, Neurosurgery and Psychiatry, 47, 970-975.
23. Wing, J. K., Curtis, R., & Beevor, A. (1996). The Health of the Nation Outcome Scales. London: Royal College of Psychiatrists.